LA WEEKLY | THE ROLL UP
Introduces CBN with 1 PUFF
The means by which we discuss cannabis have evolved drastically over the last decade. Ten years ago, the primary way a casual consumer differentiated product was by price point. The more expensive the miscellaneous bag of grass was, theoretically, the higher quality the product. Since then, as the cannabis industry has grown larger and more legitimate and we learn more and more about the individual properties of marijuana, our ability as consumers to make clearer decisions in what we buy has also grown. It began with the distinction between sativa and indica. Eventually, we broke it down even further, noting the differences in a strain’s cannabinoid properties, namely its THC and CBD percentages. Recently, however, Mark Adams and his new line, 1 PUFF, have given us an entirely new cannabinoid to consider: cannabinol, or CBN.
Mark Adams got into the cannabis industry back in 2006, when his grandfather was dying of colon cancer. After experimenting with cannabis in an effort to improve his grandfather’s condition, Mark simultaneously saw the positive impact marijuana had on his grandfather’s pain levels, while also noting the enormous number of hoops a patient had to jump through just to get their hands on it. Shortly thereafter, Mark dedicated himself to the study of cannabis, to make it more readily available to a public that could greatly benefit from its anti-inflammatory and pain-relieving qualities. Starting out with his own dispensary and laboratory in Long Beach, Mark quickly made huge strides in the study and understanding of marijuana. A past director of the Medical Cannabis Association, Mark was one of the first to note the importance of CBD, while most of his colleagues were still focusing on THC.
Mark credits much of his current understanding of cannabis to a moment he had at the Cannabinoids as Medicine Conference in 2010. At that point, Mark knew two things to be true: 1) Every strain of marijuana provided users with its own unique, individual effects, and 2) Every strain of marijuana had its own unique, individual smell. So Mark posed a very simple question to a group of scientists at that convention, a question that he calls the “question that changed cannabis.” Quite simply, “What makes the smell?” What is it in the chemistry of cannabis that creates unique scent profiles in each individual strain? The answer he got was terpenes. Up to that point, terpenes in cannabis had not been a focus for most researchers, because terpenes are not unique to the cannabis plant. Terpenes are found in all fragrant plants, which is why cannabis researchers were much more focused on the cannabinoids and those elements of cannabis that made it unique. Mark, however, had drawn a connection between a plant’s scent and its effects in consumers, and with that answer, formulated his own opinion on where the “medicine” of marijuana might really lie.
Mark took that theory and began to put it into effect in his work. Utilizing feedback and surveys from patients, he was able to better break down what strains caused what effects, and what terpenes were dominant in those strains. The real trick, however, was to be able to mimic those effects from smoking and put them in a vaporized form. This is where Mark and his team created their unique triple extraction process that is used in their 1 PUFF line. After distilling a fresh plant, terpenes are extracted from the plant at three separate points in time and are then reformulated back into the oil at the end of the process at the exact concentration that they are found in the original plant. This triple extraction process creates the “true to strain” effects of 1 PUFF. Mark and his team felt that if a person smoked a specific strain for a specific effect, then they should be able to experience in its vaporized form not only the flavor of that strain, but the effects they had chosen that strain for in the first place.
But the unique technology of 1 PUFF doesn’t stop there. Within the vaporizer itself, the product’s unique radiant heat technology heating coil plays a huge part in the overall experience. This mechanism manages to do something most vaporizers on the market have not been able to achieve: create a cooler burn while still maintaining a large volume. Even at the low temperature this heating coil creates, it still manages to give off approximately 13mg of THC per 1 puff (hence the name), compared to most products currently on the market that give out an average of 2-3mg of THC per puff, while still burning at higher temperatures. It is this technology matched with the triple extraction process that really creates the “true to strain” experience. For those consumers out there that say “vaporizers don’t really do that much for me,” this may be the product to change your mind.
Of course, as mentioned earlier, perhaps the most unique part of the 1 PUFF line is its cannabinoid formulas, most specifically its brand-new cannabinol (CBN) formula. CBN, along with CBD and THC and several other compounds, is one of the cannabinoids that make up the properties of cannabis. Up until now, most cannabis researchers have kept their cannabinoid focus on isolating THC and CBD. 1 PUFF’s Sleep product, however, brings us the first CBN product to hit the market. According to Mark and his team of researchers, CBN brings on a non-psychoactive, purely physical effect similar to CBD, but with a level of effect on the body that is nearly 10 times the amount of THC. It is their hope that this product will be helpful for a wide variety of users, from those just looking to relax, to those users who are looking for a way to deal with serious physical pain. With its new CBN formula, 1 PUFF is opening up an entirely new branch in the study of cannabinoids, and with it is just beginning its dive into the potential future benefits of CBN.
1 PUFF products are currently available in select stores, and their batteries come with a lifetime warranty. See their full line of products at their website, www.1puff.com.
Written By: Nick Walker